{
  "catalogVersion": "0.2.0",
  "source": {
    "file": "Pure_Biomedical_Evidence_Research_Metrics_Part11.xlsx",
    "sheet": "Biomedical Evidence Metrics",
    "importedAt": "2026-08-02",
    "sourceRange": "A7:R2192",
    "providedFields": [
      "Category",
      "Metric"
    ],
    "unprovidedScientificFields": [
      "Scientific Definition",
      "What It Measures",
      "Why It Matters",
      "Measurement Criteria",
      "Typical Methods of Assessment",
      "Units or Scale (if applicable)",
      "Evidence Level Where Used",
      "Applicable Study Types",
      "Related Frameworks",
      "Closely Related Metrics",
      "Common Misinterpretations",
      "Limitations",
      "Scientific Importance (1–10)",
      "Frequency of Use",
      "Maturity of Metric",
      "References or Origin"
    ],
    "sourceFieldCompleteness": null
  },
  "metric": {
    "id": "BEM-C2159",
    "name": "De Novo Mutation Validation Rate",
    "category": "Precision Medicine",
    "sourceCategory": "Variant Benchmarking and Difficult Genomic Regions",
    "assignmentBasis": "Patient-, phenotype-, genotype-, or biomarker-stratified evidence used for individualized interpretation.",
    "status": "Catalogued",
    "specificationStatus": "Scientific specification pending",
    "existingSpecificationId": null,
    "sourceRow": 2166
  }
}